Lisbon, Portugal-headquartered Hovione has completed significant expansions in Europe and the USA. The investments at the facilities in East Windsor, New Jersey, and...
Portuguese CDMO Hovione has expanded its continuous manufacturing capabilities with the start-up of a new facility at Loures. The company said it can now offer customers...
Hovione has appointed Jean-Luc Herbeaux as Hovione’s Chief Executive Officer (CEO), effective April 1, 2022. He will succeed Guy Villax, who has been the company’s CEO...
So far, the pharmaceutical industry — including CMOs/CDMOs and CROs — has responded well to the outbreak of the Covid-19 pandemic. However, the coronavirus crisis has...
11.04.2019
- The chemical industry is one of the most international sectors with activity dominated by cross border transactions. Chinese and other Asian firms have been particularly busy...
31.08.2018
- Outsourcing is about the efficiencies of globalization, expense, people, and the challenge of drug discovery. Big Pharma has consolidated and faltered over the past 15 to 20 years...
08.03.2018
- Hovione plans to withdraw from generic contrast media manufacturing to focus on other business segments including contract development and manufacturing of innovative therapies and...
